Sombras, introspección y rescate interior: un estudio de caso sobre el uso de psilocibina en contexto doméstico

César  Olea Becerra; Genara Antonia Castillo Contreras

doi:10.46363/jnph.v5i3.1

Autores/as

César Olea Becerra Universidad Católica de Trujillo https://orcid.org/0009-0005-4423-2262
Genara Antonia Castillo Contreras Universidad Católica de Trujillo https://orcid.org/0000-0003-1934-6784

DOI:

https://doi.org/10.46363/jnph.v5i3.1

Palabras clave:

Psilocibina, experiencia psicodélica, análisis temático, consumo doméstico

Resumen

Este estudio exploró las experiencias subjetivas asociadas al consumo doméstico y autónomo de hongos psilocibios en un usuario primerizo con énfasis en los procesos de autopercepción y adaptación cotidiana. Se empleó un enfoque cualitativo mediante un estudio de caso único, con análisis temático inductivo aplicado a entrevistas semiestructuradas realizadas antes y después de la experiencia, así como a observación no intrusiva durante el consumo. Los resultados revelaron la emergencia de temas centrales vinculados a la introspección, la evocación de recuerdos emocionalmente significativos y la activación de procesos de regulación afectiva espontánea. La vivencia psicodélica, desarrollada en un entorno doméstico percibido como seguro, facilitó la resignificación de experiencias pasadas y generó cambios sostenidos en la narrativa de autoconcepto de la participante. Se discuten las implicancias de estos hallazgos para la comprensión del consumo autónomo de psicodélicos fuera de contextos clínicos, y se plantea la necesidad de estrategias psicoeducativas orientadas a la reducción de riesgos y a la integración emocional de este tipo de experiencias.

Citas

Agin-Liebes, G., Nielson, E. M., Zingman, M., Kim, K., Haas, A., Owens, L. T., Rogers, U., & Bogenschutz, M. (2024). Reports of Self-Compassion and Affect Regulation in Psilocybin-Assisted Therapy for Alcohol Use Disorder: An Interpretive Phenomenological Analysis. Psychology of Addictive Behaviors, 38(1), 101–113. https://doi.org/10.1037/adb0000935 DOI: https://doi.org/10.1037/adb0000935

Aicher, H. D., Schmid, Y., & Gasser, P. (2024). Psychedelics-assisted psychotherapy: Experiences with the limited medical use of LSD, MDMA, and psilocybin in Switzerland | Psychedelika-assistierte Psychotherapie: Erfahrungen mit der beschränkten medizinischen Anwendung von LSD, MDMA und Psilocybin in d. Psychotherapie, 69(2), 98–106. https://doi.org/10.1007/s00278-024-00711-y DOI: https://doi.org/10.1007/s00278-024-00711-y

Association, W. M. (2024). World Medical Association Declaration

of Helsinki: Ethical Principles for Medical Research Involving Human Participants. JAMA. https://doi.org/10.1001/jama.2024.21972 DOI: https://doi.org/10.1001/jama.2024.21972

Bahi, C., Irrmischer, M., Franken, K., Fejer, G., Schlenker, A., Deijen, J. B., & Engelbregt, H. (2024). Effects of conscious connected breathing on cortical brain activity, mood and state of consciousness in healthy adults. Current Psychology, 43(12), 10578–10589. https://doi.org/10.1007/s12144-023-05119-6 DOI: https://doi.org/10.1007/s12144-023-05119-6

Barnett, B. S., Koons, C. J., van den Eynde, V., Gillman, P. K., & Bodkin, J. A. (2024). Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.2024.2368617 DOI: https://doi.org/10.1080/02791072.2024.2368617

C. Olea et al. Journal of Neuroscience and Public Health vol. 5 (2): 01-12, 2025

Berlowitz, I., García Torres, E., Maake, C., Wolf, U., & Martin-Soelch, C. (2023). Indigenous-Amazonian Traditional Medicine’s Usage of the Tobacco Plant: A Transdisciplinary Ethnopsychological Mixed-Methods Case Study. Plants, 12(2). https://doi.org/10.3390/plants12020346 DOI: https://doi.org/10.3390/plants12020346

Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa DOI: https://doi.org/10.1191/1478088706qp063oa

Brouwer, A., Raison, C. L., & Shults, F. L. (2024). The trajectory of psychedelic, spiritual, and psychotic experiences: implications for cognitive scientific perspectives on religion. Religion, Brain and Behavior. https://doi.org/10.1080/2153599X.2024.2349151 DOI: https://doi.org/10.1080/2153599X.2024.2349151

Campo, W. M., & Yali, A. M. (2024).Psychedelic use and psychological flexibility: The role of meaningful intention and decentering. Journal of Psychedelic Studies. https://doi.org/10.1556/2054.2024.00350 DOI: https://doi.org/10.1556/2054.2024.00350

Carhart-Harris, R., Roseman, L., Haijen, E., Erritzoe, D., R, R., Branchi, I., & Kaelen, M. (2018). Psychedelics and the essential importance of context. Journal of Psychopharmacology, 32, 026988111875471. https://doi.org/10.1177/0269881118754710 DOI: https://doi.org/10.1177/0269881118754710

Duque, H., & Aristizábal Díaz-Granados, E. T. (2019). Análisis fenomenológico interpretativo. Pensando Psicología, 15(25), 1–24. https://doi.org/10.16925/2382-3984.2019.01.03 DOI: https://doi.org/10.16925/2382-3984.2019.01.03

Engel, L. B., Thal, S., Bright, S. J., & Low, M. (2024). Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports. Journal of Psychedelic Studies. https://doi.org/10.1556/2054.2024.00377 DOI: https://doi.org/10.1556/2054.2024.00377

Fradkin, D. (2024). Breaking through the doors of perception, consciousness, and existence: to what extent does psychedelic phenomenology ontologically depend on external factors? Journal of Psychedelic Studies, 8(1), 122–141. https://doi.org/10.1556/2054.2022.00168 DOI: https://doi.org/10.1556/2054.2022.00168

Gukasyan, N., & Nayak, S. M. (2022). Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy. Transcultural Psychiatry, 59(5), 652–664. https://doi.org/10.1177/1363461520983684 DOI: https://doi.org/10.1177/1363461520983684

Hovmand, O. R., Poulsen, E. D., & Arnfred, S. (2024). Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics. Journal of Psychopharmacology, 38(1), 19–32. https://doi.org/10.1177/02698811231200019 DOI: https://doi.org/10.1177/02698811231200019

Keeler, J. L., Kan, C., Treasure, J., & Himmerich, H. (2024). Novel treatments for anorexia nervosa: Insights from neuroplasticity research. European Eating Disorders Review, 32(6), 1069–1084. https://doi.org/10.1002/erv.3039 DOI: https://doi.org/10.1002/erv.3039

C. Olea et al. Journal of Neuroscience and Public Health vol. 5 (2): 01-12, 2025

La Torre, J. T., Gallo, J., Mahammadli, M., Zalewa, D., & Williams, M. T. (2024). Experiences of psychedelic drug use among people with psychotic symptoms and disorders: Personal growth and mystical experiences. Journal of Psychedelic Studies. https://doi.org/10.1556/2054.2024.00348 DOI: https://doi.org/10.1556/2054.2024.00348

Manuel-Navarrete, D., DeLuca, S., Friso, F., & Politi, M. (2024). Ayahuasca ceremonies, relationality, and inner-outer transformations to sustainability. Evidence from Takiwasi Center in Peru. Ecosystems and People, 20(1). https://doi.org/10.1080/26395916.2024.2339227 DOI: https://doi.org/10.1080/26395916.2024.2339227

McCrone, P., Fisher, H., Knight, C., Harding, R., Schlag, A. K., Nutt, D. J., & Neill, J. C. (2023). Cost-effectiveness of psilocybin-assisted therapy for severe depression: Exploratory findings from a decision analytic model. Psychological Medicine, 53(16), 7619–7626. https://doi.org/10.1017/S0033291723001411 DOI: https://doi.org/10.1017/S0033291723001411

Mendive, F., Giovannetti, C., & García Arce, S. (2023). Ancient medicine for a modern disease: traditional Amazonian medicine to treat substance use disorders | Medicina Ancestral para una Enfermedad Moderna: Medicina Tradicional Amazónica para los Trastornos por el Uso de Sustancias. American Journal of Drug and Alcohol Abuse. https://doi.org/10.1080/00952990.2023.2264466 DOI: https://doi.org/10.1080/00952990.2023.2264466

Nordin, M., Hlynsson, J. I., Håkansson, J., & Carlbring, P. (2024). A double-edged sword: Insights from practitioners on the short and long-term negative effects

of psilocybin-assisted psychological interventions. Journal of Psychedelic Studies, 8(2), 196–203. https://doi.org/10.1556/2054.2024.00337 DOI: https://doi.org/10.1556/2054.2024.00337

Perkins, D., Ruffell, S. G. D., Day, K., Pinzon Rubiano, D., & Sarris, J. (2023). Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use. Frontiers in Neuroscience, 16. https://doi.org/10.3389/fnins.2022.879221 DOI: https://doi.org/10.3389/fnins.2022.879221

Pilecki, B., Luoma, J., & Lear, K. M. (2024). A pilot study of the effect of group-administered psilocybin on psychological flexibility and outcomes. Journal of Psychedelic Studies, 8(2), 211–218. https://doi.org/10.1556/2054.2024.00295 DOI: https://doi.org/10.1556/2054.2024.00295

Repantis, D., Koslowski, M., & Fink, S. B. (2024). Ethical aspects of therapy with psychedelics | Ethische Aspekte der Therapie mit Psychedelika. Psychotherapie, 69(2), 115–121. https://doi.org/10.1007/s00278-024-00710-z DOI: https://doi.org/10.1007/s00278-024-00710-z

Rougemont-Bücking, A., Guenot, F., Salamin, V., Gothuey, I., Duffour, C., King-Olivier, J., Girard, V., & Naudin, J. (2024). Psychedelic-augmented psychotherapy for overcoming traumatic dissociation: A review of neuroscientific and phenomenological evidence. European Journal of Trauma & Dissociation, 8(3), 100431. https://doi.org/10.1016/J.EJTD.2024.100431 DOI: https://doi.org/10.1016/j.ejtd.2024.100431

Ruffell, S. G. D., Crosland-Wood, M., Palmer, R., Netzband, N., Tsang, W., Weiss, B., Gandy,

C. Olea et al. Journal of Neuroscience and Public Health vol. 5 (2): 01-12, 2025 DOI: https://doi.org/10.46363/jnph.v5i1.1

S., Cowley-Court, T., Halman, A., McHerron, D., Terhune, D. B., & Sarris, J. (2023). Ayahuasca: A review of historical, pharmacological, and therapeutic aspects. Psychiatry and Clinical Neurosciences Reports, 2(4). https://doi.org/10.1002/pcn5.146 DOI: https://doi.org/10.1002/pcn5.146

Rush, B., Marcus, O., García, S., Loizaga-Velder, A., Spitalier, A., & Mendive, F. (2024). Ayahuasca Treatment Outcome Project (ATOP): One-Year Results from Takiwasi Center and Implications for Psychedelic Science. Journal of Studies on Alcohol and Drugs, 85(5), 607–618. https://doi.org/10.15288/jsad.23-00005 DOI: https://doi.org/10.15288/jsad.23-00005

Simonsson, O., Osika, W., Stenfors, C. U. D., Goldberg, S. B., Honk, L., & Hendricks, P. S. (2024). Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom. Psychological Medicine, 54(6), 1228–1234.

https://doi.org/10.1017/S0033291723003082 DOI: https://doi.org/10.1017/S0033291723003082

Watts, R., & Luoma, J. B. (2020). The use of the psychological flexibility model to support psychedelic assisted therapy. Journal of Contextual Behavioral Science, 15, 92–102. https://doi.org/10.1016/J.JCBS.2019.12.004 DOI: https://doi.org/10.1016/j.jcbs.2019.12.004

Weiss, B., Sleep, C. E., Beller, N. M., Erritzoe, D., & Campbell, W. K. (2023). Perceptions of psychedelic personality change, determinants of use, setting and drug moderation: Toward a holistic model. Journal of Psychedelic Studies, 7(3), 200–226. https://doi.org/10.1556/2054.2023.00291 DOI: https://doi.org/10.1556/2054.2023.00291

Wiepking, L., de Bruin, E., & Ghiţă, A. (2023). The potential of psilocybin use to enhance well-being in healthy individuals – A scoping review. Journal of Psychedelic Studies, 7(3), 184–199. https://doi.org/10.1556/2054.2023.00244 DOI: https://doi.org/10.1556/2054.2023.00244